New 'Smart Bomb' drug seeks to target advanced cancers

NCT ID NCT04064359

Recruiting now Disease control Sponsor: Oxford BioTherapeutics Ltd Source: ClinicalTrials.gov ↗

Summary

This is an early-stage study to find a safe dose and check the side effects of a new experimental drug called OBT076. The drug is designed to target and kill cancer cells that have a specific marker (CD205) and have stopped responding to standard treatments. The study will enroll about 200 adults with various advanced solid tumors to test the drug alone and in combination with other therapies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AZ Groeninge
COMPLETED

Kortrijk, Belgium
Cedars-Sinai
COMPLETED

Los Angeles, California, 90048, United States
Centre Eugène Marquis
RECRUITING

Rennes, France

Contact
Columbia University Medical Center
COMPLETED

New York, New York, 10032, United States
EuroMedica
COMPLETED

Thessaloniki, GR-54645, Greece
GHP Saint-Joseph
RECRUITING

Paris, France

Contact
Hopital Saint Antoine
COMPLETED

Paris, France
Hopital Saint Louis
RECRUITING

Paris, France

Contact
Hospital Universitario Fundacion Jimenez Diaz
RECRUITING

Madrid, 28040, Spain
ICANS - Institut de cancérologie Strasbourg
RECRUITING

Strasbourg, France

Contact
Institut Gustave Roussy - IGR
RECRUITING

Villejuif, France
Institut Jules Bordet
RECRUITING

Brussels, Belgium

Contact
Institut Paoli Calmettes
RECRUITING

Marseille, France
Mayo Clinic
COMPLETED

Phoenix, Arizona, 85084, United States
Metropolitan Hospital
COMPLETED

Athens, Greece
Moffitt Cancer Center
COMPLETED

Tampa, Florida, 33612, United States
Quantum Santa Fe
COMPLETED

Santa Fe, New Mexico, 87505, United States
START Barcelona HM Nou Delfos
RECRUITING

Barcelona, 08023, Spain
Sotiria General Hospital
RECRUITING

Athens, Greece

Contact
St. Elizabeth Healthcare
COMPLETED

Edgewood, Kentucky, 41017, United States
The State University of Iowa
ACTIVE_NOT_RECRUITING

Iowa City, Iowa, 52242, United States
UCLA
COMPLETED

Santa Monica, California, 90404, United States
University General Hospital Attikon
RECRUITING

Chaïdári, Athens, 12462, Greece

Contact Phone: •••-•••-••••

Contact

Contact
University General Hospital of Heraklion
RECRUITING

Heraklion, Greece

Contact
University Hospital Marqués de Valdecilla
RECRUITING

Santander, 39008, Spain
University of Mississippi Medical Center
COMPLETED

Jackson, Mississippi, 39216, United States
University of Pittsburgh
COMPLETED

Pittsburgh, Pennsylvania, 15260, United States

Conditions

Explore the condition pages connected to this study.

SOLID TUMOR